Live Breaking News & Updates on Joachim Burman

Stay updated with breaking news from Joachim burman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Time to Add aHSCT to Standard Care in RRMS?

73% of patients with relapsing remitting multiple sclerosis were disease free 5 years after aHSCT treatment, and more than half reported improved disability. ....

Uppsala Lan , Joachim Burman , Clinical Research Dalarna , Swedish Research Council , Marcus Wallenberg Foundation , Regional Research Council , Department Of Medical Sciences , Swedish Society Of Medicine , Swedish Society For Medical Research , Uppsala University , Kurtzke Expanded Disability Status Scale , Medical Sciences , Region Stockholm , Swedish Society , Medical Research , Neurology Neurosurgery , Multiple Sclerosis Ms , S Multiple Sclerosis , Transplantation Of Stem Cells , Ransplantation Of Hematopoietic Stem Cells , Hematopoietic Stem Cell Transplant , Stem Cell Transplantation , Stem Cell Therapy , Tem Cell Haematopoietic Stem Transplant , Sct Hematopoietic Stem Cell Transplantation Hsct Haematopoietic ,

Stem cell treatment halts MS for some patients

Stem cell treatment halts MS for some patients
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Uppsala Lan , Thomas Silfverberg , Joachim Burman , Bruce Bebo , Uppsala University Hospital , National Multiple Sclerosis Society , National Ms Society , National Multiple Sclerosis ,

Stem Cell Transplants Effective in MS

AHSCT shows long-term benefit in Swedish cohort ....

Uppsala Lan , Judy George , Joachim Burman , National Multiple Sclerosis Society , Swedish Board Of Health , Uppsala University , Pscience Media Centre , Swedish Board , Expanded Disability Status Scale , Medpage Today , Neurol Neurosurg Psychiatry ,

Stem Cell Therapy for MS: Benefits Can Outweigh the Risks

New research finds a stem cell treatment is effective and generally safe for treating relapsing-remitting multiple sclerosis. ....

United States , Uppsala Lan , Bruce Bebo , Joachim Burman , National Ms Society , Sclerosis At Stanford University , European Society For Blood , National Ms Society Guidelines , Department Of Medical Sciences At Uppsala University , Clinical Associate Professor Of Neurology Neurological Sciences , Neurology Neurosurgery , Medical Sciences , Uppsala University , European Society , Marrow Transplantation , Executive Vice President , Christopher Lock , Clinical Associate Professor , Neurological Sciences , Clinical Trials Director , Multiple Sclerosis ,

Stem cell transplants may reverse disability for some MS patients

A new study is strengthening the evidence that stem cell transplants can be highly effective for some people with multiple sclerosis sending the disease into remission for years, and sometimes reversing disability. ....

Uppsala Lan , Joachim Burman , Bruce Bebo , National Multiple Sclerosis Society , Uppsala University Hospital , National Ms Society , National Multiple Sclerosis , Stem Cell Transplants , Stem Cells , Joachim Burman , National Ms Society , Disease Activity , Immune System ,